miR-1268a regulates ABCC1 expression to mediate temozolomide resistance in glioblastoma

MicroRNA-335-5p and -3p synergize to inhibit estrogen receptor alpha expression and promote tamoxifen resistance

(2017) Elizabeth C. Martin et al.   FEBS LETTERS

Genomic profiling of long non-coding RNA and mRNA expression associated with acquired temozolomide resistance in glioblastoma cells

(2017) Huijun Zeng et al.   INTERNATIONAL JOURNAL OF ONCOLOGY

MiR-181b modulates chemosensitivity of glioblastoma multiforme cells to temozolomide by targeting the epidermal growth factor receptor

(2017) Yunxiang Chen et al.   JOURNAL OF NEURO-ONCOLOGY

Hedgehog signaling pathway affects the sensitivity of hepatoma cells to drug therapy through the ABCC1 transporter

(2017) Jia Ding et al.   LABORATORY INVESTIGATION

miR-194-5p/BCLAF1 deregulation in AML tumorigenesis

(2017) C Dell'Aversana et al.   LEUKEMIA

miRNA-34c-5p inhibits amphiregulin-induced ovarian cancer stemness and drug resistance via downregulation of the AREG-EGFR-ERK pathway

(2017) S-L Tung et al.   Oncogenesis

miR-140-5p attenuates chemotherapeutic drug-induced cell death by regulating autophagy through inositol 1,4,5-trisphosphate kinase 2 (IP3k2) in human osteosarcoma cells

(2016) R. Wei et al.   BIOSCIENCE REPORTS

Over-expression of miR-451a can enhance the sensitivity of breast cancer cells to tamoxifen by regulating 14-3-3ζ, estrogen receptor α, and autophagy

(2016) Zhen-Ru Liu et al.   LIFE SCIENCES

Progress in glioma diagnosis, classification and treatment

(2016) Patrick Y. Wen et al.   Nature Reviews Neurology

The tumor microenvironment underlies acquired resistance to CSF-1R inhibition in gliomas

(2016) D. F. Quail et al.   SCIENCE

MiR-34a-5p promotes the multi-drug resistance of osteosarcoma by targeting the CD117 gene

(2016) Youguang Pu et al.   Oncotarget

MiR-139-5p reverses CD44+/CD133+-associated multidrug resistance by downregulating NOTCH1 in colorectal carcinoma cells

(2016) Ke Xu et al.   Oncotarget

Prognostic significance of miR-1268a expression and its beneficial effects for post-operative adjuvant transarterial chemoembolization in hepatocellular carcinoma

(2016) Yun-Long Lu et al.   Scientific Reports

Expression of dynein, cytoplasmic 2, heavy chain 1 (DHC2) associated with glioblastoma cell resistance to temozolomide

(2016) Hai Wang et al.   Scientific Reports

An overview of microRNAs

(2015) Scott M. Hammond   ADVANCED DRUG DELIVERY REVIEWS

Targeting Hedgehog signaling pathway and autophagy overcomes drug resistance of BCR-ABL-positive chronic myeloid leukemia

(2015) Xian Zeng et al.   Autophagy

MicroRNA-134 modulates resistance to doxorubicin in human breast cancer cells by downregulating ABCC1

(2015) Lin Lu et al.   BIOTECHNOLOGY LETTERS

Toward an effective strategy in glioblastoma treatment. Part II: RNA interference as a promising way to sensitize glioblastomas to temozolomide

(2015) Khaled Messaoudi et al.   DRUG DISCOVERY TODAY

Toward an effective strategy in glioblastoma treatment. Part I: resistance mechanisms and strategies to overcome resistance of glioblastoma to temozolomide

(2015) Khaled Messaoudi et al.   DRUG DISCOVERY TODAY

miR-7 modulates chemoresistance of small cell lung cancer by repressing MRP1/ABCC1

(2015) Huanxin Liu et al.   INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY

Involvement of miR-133a and miR-326 in ADM resistance of HepG2 through modulating expression of ABCC1

(2015) Jin Ma et al.   JOURNAL OF DRUG TARGETING

AKT2-knockdown suppressed viability with enhanced apoptosis, and attenuated chemoresistance to temozolomide of human glioblastoma cells in vitro and in vivo

(2015) Yicheng Lu et al.   OncoTargets and Therapy

Inhibition of multidrug resistance protein 1 (MRP1) improves chemotherapy drug response in primary and recurrent glioblastoma multiforme

(2015) Amanda Tivnan et al.   Frontiers in Neuroscience

MicroRNA-1246 expression associated with CCNG2-mediated chemoresistance and stemness in pancreatic cancer

(2014) S Hasegawa et al.   BRITISH JOURNAL OF CANCER

Tumor heterogeneity and plasticity as elusive drivers for resistance to MAPK pathway inhibition in melanoma

(2014) A Roesch   ONCOGENE

Targeting Multidrug Resistance Protein 1 (MRP1, ABCC1): Past, Present, and Future

(2013) Susan P.C. Cole   Annual Review of Pharmacology and Toxicology

p53 in breast cancer subtypes and new insights into response to chemotherapy

(2013) Philippe Bertheau et al.   BREAST

The Synergistic Therapeutic Effect of Temozolomide and Hyperbaric Oxygen on Glioma U251 Cell Lines is Accompanied by Alterations in Vascular Endothelial Growth Factor and Multidrug Resistance-Associated Protein-1 Levels

(2013) X-Y Lu et al.   JOURNAL OF INTERNATIONAL MEDICAL RESEARCH

MicroRNAs and other non-coding RNAs as targets for anticancer drug development

(2013) Hui Ling et al.   NATURE REVIEWS DRUG DISCOVERY

Inhibition of Histone Deacetylation Potentiates the Evolution of Acquired Temozolomide Resistance Linked to MGMT Upregulation in Glioblastoma Xenografts

(2012) G. J. Kitange et al.   CLINICAL CANCER RESEARCH

Detection of ABCC1 expression in classical Hodgkin lymphoma is associated with increased risk of treatment failure using standard chemotherapy protocols

(2012) Wesley Greaves et al.   Journal of Hematology & Oncology

Glioblastoma: From Molecular Pathology to Targeted Treatment

(2011) Timothy F. Cloughesy et al.   Annual Review of Pathology-Mechanisms of Disease

Involvement of miR-326 in chemotherapy resistance of breast cancer through modulating expression of multidrug resistance-associated protein 1

(2009) Zhongxing Liang et al.   BIOCHEMICAL PHARMACOLOGY

Application of massively parallel sequencing to microRNA profiling and discovery in human embryonic stem cells

(2008) R. D. Morin et al.   GENOME RESEARCH